在转移性三阴性乳腺癌中,ABL酶调节EZH2酸化和信号
bioRxiv : the preprint server for biology
|March 3, 2025
概括
在三阴性乳腺癌 (TNBC) 中准ABL激酶会改变像PRC2.2这样的表观遗传调节者. 结合ABL和EZH2抑制剂显示出协同作用,减少TNBC细胞存活率和小鼠转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 三阴性乳腺癌 (TNBC) 是具有不良结果的侵略性.
- 表观遗传调节者与TNBC转移有关.
- 已知ABL激酶可以促进乳腺癌转移.
研究的目的:
- 探索ABL激酶在TNBC转移中的表观遗传调节中的作用.
- 为了研究ABL激酶和PRC2复合体之间的功能联系.
- 确定TNBC的新型治疗策略.
主要方法:
- 在骨转移的TNBC细胞中,ABL激酶的非激活.
- 分析与PRC2复合体相关的基因特征.
- 研究FAK-CDK1信号轴和EZH2酸化.
- 评估ABL和EZH2抑制剂的组合疗法在体外和体内小鼠模型中.
主要成果:
- 在TNBC细胞中,ABL激酶失活丰富了PRC2复杂基因特征.
- 通过FAK-CDK1信号传递,ABL的失活促进了EZH2-T487的酸化.
- 化EZH2表现出对c-MYC和ZMYND8.8的改变结合.
- 结合ABL和EZH2抑制协同减少TNBC细胞存活率和转移.
结论:
- 在TNBC转移中,ABL激酶调节表观遗传过程,包括PRC2活性.
- 针对ABL-EZH2轴为TNBC提供了一个潜在的治疗策略.
- 与ABL和EZH2抑制剂的联合治疗显示出显著的抗转移效应,并在临床前模型中改善了生存率.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


